Protagonist Therapeutics PTGX

$ 46.12 10.72%

Quarterly report 2024-Q3
added 11-07-2024

Protagonist Therapeutics Financial Ratios 2011-2024 | PTGX

Annual Financial Ratios Protagonist Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
P/E	-21.3	-9.3	-10.8	-10.8	-2.5	-4.6	-10.5	-3.3	-	-	-	-	-
P/S	28.0	44.5	49.6	24.9	822.8	5.9	19.4	-	-	-	-	-	-
EPS	-1.4	-2.6	-2.7	-1.9	-3.0	-1.7	-2.1	-5.8	-59.3	-49.4	-	-	-
EV (Enterprise Value)	1.52 B	1.09 B	1.28 B	640 M	232 M	126 M	326 M	108 M	1.19 M	2.37 M	-	-	-
EBITDA per Share	-1.63	-2.66	-2.7	-1.85	-3.01	-1.87	-2.12	-4.98	-	-	-	-	-
EV/EBITDA	-10.1	-10.7	-2.1	-2.4	-7.5	-3.1	-	-	-	-	-
PEG	-3.73	-0.84	100.33	-0.33	0.03	-0.28	-0.16	0.05	-	-	-	-	-
P/B	5.0	5.5	4.5	2.5	2.4	1.6	3.2	1.4	-	-	-	-	-
P/CF	-23.9	-10.9	-12.6	-9.8	-4.5	-3.6	121.2	-4.0	-	-	-	-	-
ROE %	-23.45	-59.09	-41.85	-23.66	-96.53	-34.59	-30.64	-42.46	-	-	-	-	-
ROA %	-22.06	-51.38	-36.11	-20.39	-49.82	-27.91	-22.57	-39.55	-	-	-	-	-
ROCE %	-27.82	-60.93	-41.95	-23.07	-67.38	-37.30	-31.27	-37.31	-	-	-	-	-
Current Ratio	16.8	7.7	7.3	7.2	4.1	5.3	3.5	12.9	-	-	-	-	-
DSO	-	-	-	-	10673.5	71.0	57.5	-	-	-	-	-	-
DIO	-	-	-	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Financial Ratios Protagonist Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
EPS	-0.54	-0.5	3.41	-	-0.58	-0.68	-0.67	-	-0.64	-0.84	-0.43	-	-0.7	-0.69	-0.54	-	-0.21	-0.59	-0.72	-0.63	-0.61	-1.18	-0.58	-0.57	-0.38	-0.41	-0.36	-0.15	-0.29	-0.89	-0.84	-0.67	-0.87	-19.07	-40.96	-20.31	-12.79	-13.78	-11.75	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA per Share	-	-	3.39	-	-	-	-0.71	-	-0.64	-0.84	-0.43	-	-0.69	-0.69	-0.54	-	-0.19	-0.54	-0.7	-0.64	-0.62	-1.26	-0.6	-0.66	-0.39	-0.42	-0.39	-0.17	-0.28	-0.89	-0.85	-0.68	-0.81	-18.1	-24.2	-18.4	-14.2	-12.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROE %	13.81	8.76	1.34	-39.97	-52.79	-54.32	-56.56	-35.07	-45.32	-42.76	-36.07	-28.14	-30.91	-23.43	-21.75	-16.90	-38.79	-56.53	-86.07	-96.53	-86.96	-74.21	-45.42	-34.59	-24.80	-21.04	-25.76	-30.64	-40.95	-45.04	-40.73	-42.46	-9.57	11.11	30.97	44.38	24.34	11.75	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROA %	12.13	7.30	0.28	-36.40	-47.46	-48.20	-42.21	-23.09	-32.15	-24.13	-31.76	-24.74	-27.13	-20.47	-18.82	-14.57	-25.86	-34.06	-46.91	-49.82	-48.47	-44.14	-31.52	-27.91	-19.83	-16.51	-19.45	-22.57	-32.67	-37.26	-35.67	-39.55	-64.59	-80.29	-94.42	-81.92	-44.92	-21.68	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROCE %	9.17	4.28	-2.96	-43.75	-57.01	-57.59	-58.65	-35.72	-46.01	-43.04	-36.22	-28.19	-30.97	-23.46	-21.34	-16.34	-37.97	-56.66	-89.42	-100.70	-92.76	-79.64	-48.57	-37.57	-26.78	-22.57	-26.90	-31.42	-41.52	-45.54	-41.10	-37.31	-6.04	16.79	36.14	44.18	25.93	11.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.4	8.4	9.1	16.8	11.8	12.1	10.1	7.7	7.3	-	7.5	7.3	8.6	8.6	7.7	7.2	7.2	7.2	7.2	2.1	2.1	2.1	2.1	5.2	5.2	5.2	5.2	3.8	3.8	3.8	3.8	14.6	14.6	14.6	-	2.8	2.8	2.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DSO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DIO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency